mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-0365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cisplatin Sensitivity and Thermochemosensitisation in Thermotolerant cDDP-sensitive and -Resistant Cell Lines

British Journal of Cancer
Cancer ResearchOncology
1995English

Combination Chemotherapy of Paclitaxel and Cisplatin Induces Apoptosis With BCL-2 Phosphorylation in a Cisplatin-Resistant Human Epidermoid Carcinoma Cell Line

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2003English

Survivin Is a Therapeutic Target in Merkel Cell Carcinoma

Science Translational Medicine
Medicine
2012English

Inhibition of Caspase-9 Activity in Cisplatin-Resistant Head and Neck Squamous Cell Carcinoma.

Journal of Otolaryngology of Japan
Otorhinolaryngology
2002English

Clear Cell Carcinoma of the Ovary Arising in a Mucinous Cystadenoma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2001English

Establishment and Characteristics of a Cisplatin-Resistant KB Cell Line.

Practica Otologica
Otorhinolaryngology
1990English

Transcriptional Up-Regulation of SOD1 by CEBPD: A Potential Target for Cisplatin Resistant Human Urothelial Carcinoma Cells

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

VRK1 Promotes Cisplatin Resistance by Up-Regulating C-Myc via C-Jun Activation and Serves as a Therapeutic Target in Esophageal Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy